Abstract
Among various baseline clinical factors, only the Fluid-Attenuated Inversion Recovery Vascular Hyperintensity (FVH) score might have implications for 3-month outcome and 6-month survival of acute stroke (AS) patients after intravenous thrombolysis (IVT). Baseline FVH score showed great potential to predict the prognosis of the AS patients.
Introduction
In the management of acute ischemic stroke, particularly those involving large vessel occlusions (LVO), intravenous thrombolysis (IVT) remains a critical first-line intervention. However, clinical outcomes following "clot-busting" therapy are highly variable. Predicting which patients will achieve functional independence versus those at risk of poor outcomes is a significant challenge. While traditional risk factors like age and admission NIHSS scores are used, they often lack sufficient prognostic precision. This study investigates the Fluid-Attenuated Inversion Recovery Vascular Hyperintensity (FVH) sign—a radiological marker of slow, retrograde collateral blood flow—as a potential "crystal ball" for long-term patient prognosis.
Methods
The researchers conducted a retrospective analysis of 190 acute stroke patients with LVO who underwent IVT at Nanjing First Hospital. Prior to treatment, all patients received 3.0T MRI scans, including FLAIR and DWI sequences.
The FVH score was determined by two blinded neurologists who assessed the spatial distribution of hyperintensities in cortical areas on a scale of 0 to 7. A higher score reflects more extensive visible vascular hyperintensity, indicating robust collateral circulation.
Patient outcomes were evaluated using the modified Rankin Scale (mRS) at 1, 3, and 6 months post-stroke. Statistical tools, including multivariate logistic regression and Kaplan-Meier survival analysis, were employed to identify independent predictors of recovery and survival.
Key Results
The study revealed that the baseline FVH score is a highly effective prognostic tool. It achieved an Area Under the Curve (AUC) of 0.853, with a sensitivity of 86.4% and a specificity of 82.4% for predicting 3-month outcomes.
Crucially, the FVH score was the only baseline clinical factor found to independently predict 6-month survival. Patients with high FVH scores (4–7) exhibited significantly higher survival rates compared to those with low scores (0–3) (log-rank P = 0.031).
Furthermore, lower FVH scores, along with high admission NIHSS scores and elevated fasting blood glucose, were identified as primary independent risk factors for poor prognosis.
Discussion and Insights
The findings support the "collateral" theory of the FVH sign. Rather than indicating poor outcomes as some previous studies suggested, these bright signals in the context of LVO appear to represent "backup plumbing"—collateral vessels that maintain blood flow to threatened brain tissue when the primary artery is blocked.
There is a clear inverse relationship between FVH scores and stroke severity. Patients with higher scores typically presented with less severe symptoms at discharge and achieved better functional recovery months later. This suggests that the FVH score can serve as a reliable imaging biomarker for clinical decision-making and patient stratification.
Limitations
While promising, the study has limitations. It focused exclusively on patients with large vessel occlusions, meaning the results may not generalize to other stroke subtypes. Additionally, the retrospective design and the recording of survival in months rather than days suggest a need for more granular, prospective studies with longer follow-up periods to fully validate the FVH score's universal utility.
Summary updated